Ribonucleotide Reductase Subunit M2 Predicts Survival in Subgroups of Patients with Non-Small Cell Lung Carcinoma: Effects of Gender and Smoking Status

<div><p>Background</p><p>Ribonucleotide reductase catalyzes the conversion of ribonucleotide diphosphates to deoxyribonucleotide diphosphates. The functional enzyme consists of two subunits - one large (RRM1) and one small (RRM2 or RRM2b) subunit. Expression levels of each subunit have been implicated in prognostic outcomes in several different types of cancers.</p><p>Experimental Design</p><p>Immunohistochemistry for RRM1 and RRM2 was performed on a lung cancer tissue microarray (TMA) and analyzed. 326 patients from the microarray were included in this study.</p><p>Results</p><p>In non-small cell lung cancer (NSCLC), RRM2 expression was strongly predictive of disease-specific survival in women, non-smokers and former smokers who had quit at least 10 years prior to being diagnosed with lung cancer. Higher expression was associated with worse survival. This was not the case for men, current smokers and those who had stopped smoking for shorter periods of time. RRM1 was not predictive of survival outcomes in any subset of the patient group.</p><p>Conclusion</p><p>RRM2, but not RRM1, is a useful predictor of survival outcome in certain subsets of NSCLC patients.</p></div

Multivariate Cox proportional hazards model for women.

<p>Multivariate Cox proportional hazards model for women.</p

Kaplan Meier curves for RRM1 and RRM2 in all patients.

<p>(A) cytoplasmic RRM2, split by median expression levels (p = 0.002, hazard ratio = 1.70). (B) cytoplasmic RRM1, split by median expression levels (p = 0.497, hazard ratio = 1.12).</p

Univariate Cox model for cytoplasmic RRM1, cytoplasmic RRM2 and nuclear RRM2 as predictors of survival in patient subgroups.

<p>Univariate Cox model for cytoplasmic RRM1, cytoplasmic RRM2 and nuclear RRM2 as predictors of survival in patient subgroups.</p

Histograms of RRM1 and RRM2 staining patterns.

<p>Distribution for staining intensity (measured by integrated intensity: [(3x) + (2y) + (1z)] / 100 where x, y, and z are % staining at intensity 3, 2, and 1, respectively) of (A) cytoplasmic RRM1, (B) cytoplasmic RRM2 and (C) nuclear RRM2. Although variable, overall staining was stronger for cytoplasmic RRM1. Many patients showed weak or negative staining.</p

Barplots for relative RRM1 and RRM2 protein expression levels in cytoplasm (integrated intensity, scale from 0 to 3) by (A) histology and (B) grade.

<p>Both RRM1 and RRM2 expression were higher in squamous carcinoma than adenocarcinoma (p < 10^–5). RRM1 expression did not correlate with tumor grade (rho = 0.04, p = 0.55) while RRM2 expression correlated positively with grade (rho = 0.44, p < 10^–5 for cytoplasm and rho = 0.36, p < 10^–5 for nucleus).</p